Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
doi: 10.1136/rmdopen-2022-002686 78 MullerDRPStenversDJMalekzadehAHollemanFPainterRCSiegelaarSE
Novo Nordisk has also cited indirect comparison data suggesting that fewer patients discontinued oral semaglutide due to side effects compared with orforglipron, though the companies and independent commentators note the significant methodological limitations of such comparisons in the absence of a head-to-head obesity trial
In a separate study that evaluated patient perceptions of the injection devices for liraglutide and dulaglutide, the dulaglutide device was associated with a slightly higher score for ease of use and convenience [128]
US$ 20.33
US$ 27.28
US$ 27.19
US$ 25.15
US$ 28.06
